Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 5, 2026, 6:12 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1921–1944 of 2,428 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Learning Disorders Clear all

Conditions: Prevention of Stroke or Systemic Embolism, Atrial Fibrillation
Interventions: Asundexian (BAY2433334), Apixaban, Asundexian matching placebo, Apixaban matching placebo; Drug
Lead sponsor: Bayer; Industry
Eligibility: 18 Years and older
Enrollment: 14,830 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2024
U.S. locations: 163
States / cities: Dothan, Alabama • Fairhope, Alabama • Mobile, Alabama + 144 more

Conditions: Healthy, Schizophrenia
Interventions: Not listed
Lead sponsor: National Institute of Mental Health (NIMH); NIH
Eligibility: 18 Years to 60 Years
Enrollment: 112 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 1999 – 2010
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Metastatic Castrate Resistant Prostate Cancer (mCRPC)
Interventions: PF-06821497, Docetaxel, Enzalutamide; Drug
Lead sponsor: Pfizer; Industry
Eligibility: 18 Years and older · Male only
Enrollment: 609 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2028
U.S. locations: 70
States / cities: Homewood, Alabama • Chandler, Arizona • Gilbert, Arizona + 49 more

Conditions: Klinefelter Syndrome, Trisomy X, XYY Syndrome, XXXY and XXXXY Syndrome, Xxyy Syndrome, Xyyy Syndrome, Xxxx Syndrome, Xxxxx Syndrome, Xxxyy Syndrome, Xxyyy Syndrome, Xyyyy Syndrome, Male With Sex Chromosome Mosaicism
Interventions: Assessments of Development and Growth; Other
Lead sponsor: University of Colorado, Denver; Other
Eligibility: 6 Weeks to 13 Months
Enrollment: 300 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2028
U.S. locations: 2
States / cities: Aurora, Colorado • Philadelphia, Pennsylvania

Conditions: Urinary Incontinence
Interventions: VA Video Connect, MyHealtheBladder; Behavioral
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: 18 Years and older · Female only
Enrollment: 286 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2025
U.S. locations: 3
States / cities: Birmingham, Alabama • Decatur, Georgia • Durham, North Carolina

Conditions: Weight Loss Trial, Cardiometabolic Syndrome, Hypertension, Dyslipidemia, Pre-diabetes, Type 2 Diabetes Mellitus
Interventions: Partnership for Improving Lifestyle Intervention (PILI) Lifestyle Program + Social Determinants of Health (SDOH) Component; Behavioral
Lead sponsor: University of Hawaii; Other
Eligibility: 18 Years and older
Enrollment: 242 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2025
U.S. locations: 4
States / cities: Fayetteville, Arkansas • Springdale, Arkansas • Honolulu, Hawaii

Conditions: Otitis Media Acute
Interventions: OtoSight Middle Ear Scope; Device
Lead sponsor: PhotoniCare, Inc.; Industry
Eligibility: 6 Months to 17 Years
Enrollment: 700 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2026
U.S. locations: 7
States / cities: Washington D.C., District of Columbia • Miami, Florida • Orlando, Florida + 4 more

Conditions: Encephalopathy, Birth Defect, Intellectual Disability, Multiple Congenital Anomaly, Metabolic Disease, Epilepsy, Neuro-Degenerative Disease, Cerebral Palsy, Developmental Delay, Developmental Defect
Interventions: Whole Exome Sequencing; Diagnostic Test
Lead sponsor: University of California, San Francisco; Other
Eligibility: Up to 25 Years
Enrollment: 529 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2022
U.S. locations: 4
States / cities: Fresno, California • Oakland, California • San Francisco, California

Conditions: Stroke
Interventions: Not listed
Lead sponsor: National Institute of Neurological Disorders and Stroke (NINDS); NIH
Eligibility: 18 Years to 90 Years
Enrollment: 70 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: Started 2006
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Status Epilepticus
Interventions: Verbal Instructions Educational Intervention, Video Educational Intervention, Mannequin Educational Intervention; Other
Lead sponsor: Boston Children's Hospital; Other
Eligibility: 2 Years to 80 Years
Enrollment: 17 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2019
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Anxiety
Interventions: Visually Immersive Video, Standard of Care; Behavioral
Lead sponsor: Baptist Health South Florida; Other
Eligibility: 18 Years and older
Enrollment: 200 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Miami, Florida

Conditions: Type 2 Diabetes, Diabetes
Interventions: Diabetes Self Management Program; Behavioral
Lead sponsor: Stanford University; Other
Eligibility: 18 Years and older
Enrollment: 1,000 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2017
U.S. locations: 1
States / cities: Stanford, California

Conditions: Schizophrenia
Interventions: Interactive Website on management of schizophrenia, Written materials and video on management of schizophrenia; Behavioral
Lead sponsor: Johns Hopkins Bloomberg School of Public Health; Other
Eligibility: 13 Years and older
Enrollment: 56 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2007
U.S. locations: 2
States / cities: Baltimore, Maryland

Conditions: Chronic Low-back Pain, Catastrophizing Pain, Kinesiophobia
Interventions: Transcranial Direct Current Stimulation, Pain Neuroscience Education; Device · Behavioral
Lead sponsor: High Point University; Other
Eligibility: 18 Years to 65 Years
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2023
U.S. locations: 1
States / cities: High Point, North Carolina

Conditions: Non-muscle Invasive Bladder Cancer
Interventions: PF-08052667, Sasanlimab, BCG, PF-02921367; Drug
Lead sponsor: Pfizer; Industry
Eligibility: 18 Years and older
Enrollment: 294 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2033
U.S. locations: 54
States / cities: Birmingham, Alabama • Ruskin, Florida • Tampa, Florida + 21 more

Conditions: Meningococcal Disease
Interventions: PENBRAYA; Biological
Lead sponsor: Pfizer; Industry
Eligibility: 10 Years to 25 Years · Female only
Enrollment: 50 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2032
U.S. locations: 1
States / cities: New York, New York

Conditions: Velocardiofacial Syndrome
Interventions: Challenging Our Minds Program; Behavioral
Lead sponsor: State University of New York - Upstate Medical University; Other
Eligibility: 12 Years to 16 Years
Enrollment: 37 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2015
U.S. locations: 1
States / cities: Syracuse, New York

Conditions: Type 2 Diabetes Mellitus
Interventions: Diabetes Self-Management Education and Support (DSMES) plus Tai Chi Easy (TCE)™; Behavioral
Lead sponsor: University of Arizona; Other
Eligibility: 40 Years to 64 Years
Enrollment: 28 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024
U.S. locations: 1
States / cities: Tucson, Arizona

Conditions: Diabetes Mellitus, Type 2, Sleep
Interventions: Sleep education, Diet only; Behavioral
Lead sponsor: Michigan State University; Other
Eligibility: 18 Years and older
Enrollment: 22 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2022
U.S. locations: 1
States / cities: East Lansing, Michigan

Conditions: Anxiety Disorders and Symptoms, Depressive Symptoms
Interventions: The Unified Protocol for Transdiagnostic Treatment of Emotional Disorders (UP), Space for depression, Space for resilience; Behavioral
Lead sponsor: Boston University Charles River Campus; Other
Eligibility: 18 Years and older
Enrollment: 1,800 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2027
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Substance Use Disorder (SUD)
Interventions: Not listed
Lead sponsor: Evidation Health; Industry
Eligibility: 21 Years and older
Enrollment: 1,910 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2028
U.S. locations: 1
States / cities: San Mateo, California

Conditions: Dementia, Alzheimer Disease
Interventions: educational program, by telephone; Behavioral
Lead sponsor: US Department of Veterans Affairs; Federal
Eligibility: Not listed
Enrollment: 160 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2007
U.S. locations: 2
States / cities: Albany, New York • Buffalo, New York

Conditions: Duchenne Muscular Dystrophy (DMD), Cardiomyopathy, Becker Muscular Dystrophy, Carrier of Duchenne Muscular Dystrophy
Interventions: Not listed
Lead sponsor: Vanderbilt University Medical Center; Other
Eligibility: Not listed
Enrollment: 1,000 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2029
U.S. locations: 9
States / cities: Sacramento, California • Washington D.C., District of Columbia • Chicago, Illinois + 6 more

Conditions: Skin Cancer
Interventions: education about sun protection, biometric feedback, dermatologist skin exam; Behavioral · Other
Lead sponsor: Dana-Farber Cancer Institute; Other
Eligibility: 18 Years and older
Enrollment: 634 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2007 – 2008
U.S. locations: 1
States / cities: Boston, Massachusetts

Search by objective public record fields.

A Study to Learn How Well the Study Treatment Asundexian Works and How Safe it is Compared to Apixaban to Prevent Stroke or Systemic Embolism in People With Irregular and Often Rapid Heartbeat (Atrial Fibrillation), and at Risk for Stroke

Eye Blink Response in Healthy Volunteers and Adults With Schizophrenia

A Study to Learn About the Investigational Medicine Called PF-06821497 (Mevrometostat) in Men With mCRPC Who Were Previously Treated With Abiraterone Acetate for Prostate Cancer (MEVPRO-1).

The eXtroardinarY Babies Study: Natural History of Health and Neurodevelopment in Infants and Young Children With Sex Chromosome Trisomy

Remote Access to Urinary Incontinence Treatment for Women Veterans

Peau o le Vasa: Analysis of the Efficacy and Feasibility of the PILI Lifestyle Program (PLP) + Social Determinants of Health (SDOH) Intervention and Adaptation of SDOH Measures Pilot Study

Otitis Treatment With OtoSight™ - Modification of Antibiotic Treatment Intervention in Children

Clinical Utility of Pediatric Whole Exome Sequencing

Tactile Learning in Stroke Patients

Seizure Rescue Medication: Caregiver Education in a Simulation Setting

Impact of Immersive Video Education on Cardiothoracic Surgery Anxiety and Outcomes

Improving Self Management Skills of Older Adults With Diabetes

Effectiveness of an Interactive Educational Website for Improving the Quality of Mental Health Care for People With Schizophrenia

The Effect of Combining Pain Neuroscience Education and Transcranial Direct Current Stimulation on Pain Catastrophizing, Kinesiophobia, and Pain in Patients With Chronic Low Back Pain

A Study to Learn About the Study Medicine PF-08052667 in People With Bladder Cancer

A Study to Learn About the Safety of PENBRAYA During Pregnancy

Computerized Cognitive Skills Training for Adolescents With Velocardiofacial Syndrome

Diabetes Self-Management Plus Tai Chi Easy

Diabetes Education and A1c Study

Using Machine Learning to Optimize User Engagement and Clinical Response to Digital Mental Health Interventions

Research and Engagement on Substance Use: Harnessing Awareness and Personalized Education (RESHAPE) to Improve Well-being and Self-efficacy

Telehealth Education Program for Caregivers of Veterans With Dementia

Modeling Mortality in Duchenne Muscular Dystrophy Cardiomyopathy: Identification of Surrogate Outcome Measures for DMD Drug Trials

Skin Cancer Screening and Education at Beaches